| Characterization of myocardial microstructure and function in an experimental model of isolated subendocardial damage N Beyhoff, D Lohr, A Foryst-Ludwig, R Klopfleisch, S Brix, J Grune, ... Hypertension 74 (2), 295-304, 2019 | 33 | 2019 |
| Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage A Thiele, K Luettges, D Ritter, N Beyhoff, E Smeir, J Grune, JS Steinhoff, ... Cardiovascular research 118 (11), 2488-2505, 2022 | 25 | 2022 |
| Finerenone reduces renal RORγt γδ T cells and protects against cardiorenal damage K Luettges, M Bode, JN Diemer, J Schwanbeck, EK Wirth, R Klopfleisch, ... American Journal of Nephrology 53 (7), 552-564, 2022 | 10 | 2022 |
| Cardioprotective effects of palmitoleic acid (C16: 1n7) in a mouse model of catecholamine-induced cardiac damage are mediated by PPAR activation IR Betz, SJ Qaiyumi, M Goeritzer, A Thiele, S Brix, N Beyhoff, J Grune, ... International Journal of Molecular Sciences 22 (23), 12695, 2021 | 8 | 2021 |
| Liver X receptor agonist AZ876 induces beneficial endogenous cardiac lipid reprogramming and protects against isoproterenol‐induced cardiac damage D Ritter, M Goeritzer, A Thiele, A Blumrich, N Beyhoff, K Luettges, E Smeir, ... Journal of the American Heart Association 10 (14), e019473, 2021 | 6 | 2021 |
| Assessment of myocardial microstructure in a murine model of obesity-related cardiac dysfunction by diffusion tensor magnetic resonance imaging at 7T D Lohr, A Thiele, M Stahnke, V Braun, E Smeir, J Spranger, S Brachs, ... Frontiers in Cardiovascular Medicine 9, 839714, 2022 | 5 | 2022 |
| Myocardial Infarction After High-Dose Catecholamine Application—A Case Report From an Experimental Imaging Study N Beyhoff, D Lohr, A Thiele, A Foryst-Ludwig, R Klopfleisch, LM Schreiber, ... Frontiers in Cardiovascular Medicine 7, 580296, 2020 | 4 | 2020 |
| Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging D Lohr, A Thiele, M Stahnke, VM Braun, R Klopfleisch, O Klein, S Dresen, ... Basic Research in Cardiology, 1-13, 2024 | | 2024 |
| Characterization of Anthracycline-induced Cardiotoxicity by 7T Diffusion Tensor Magnetic Resonance Imaging N Beyhoff, D Lohr, A Thiele, V Braun, M Stahnke, R Klopfleisch, O Klein, ... Journal of Cardiovascular Magnetic Resonance 26, 2024 | | 2024 |
| Foxo3a and cardiac myofibroblast transdifferentiation after myocardial infarction Z Karadeniz, P Schenkenberger, H Maatz, E Lindberg, T Haase, A Thiele, ... European Heart Journal 44 (Supplement_2), ehad655. 3121, 2023 | | 2023 |
| Verbesserung des Katecholamin-induzierten Herzschadens durch pharmakologische Inhibition der Adipozyten-Triglycerid-Lipase (ATGL) im Fettgewebe mittels Atglistatin A Thiele | | 2023 |
| Pharmacological inhibition of adipose tissue Adipose Triglyceride Lipase (ATGL) by Atglistatin prevents catecholamine-induced myocardial damage (Jun, cvab182, 2021) A Thiele CARDIOVASCULAR RESEARCH 118 (11), 2560-2560, 2022 | | 2022 |
| Finerenone reduces renal RORgt gd T-Cells and protects against cardiorenal damage K Luettges, M Bode, A Thiele, D Ritter, R Klopfleisch, K Kappert, ... European Heart Journal 42 (Supplement_1), ehab724. 3265, 2021 | | 2021 |
| The LXR-agonist AZ876 attenuates cardiac damage in an isoproterenol induced HFpEF-like cardiomyopathy model D Ritter, A Blumrich, A Thiele, E Smeir, K Luettges, N Beyhoff, J Grune, ... EUROPEAN JOURNAL OF HEART FAILURE 21, 575-576, 2019 | | 2019 |
| Pharmacological inhibition of non-cardiac ATGL by Atglistatin improves myocardial deformation in a murine model of cardiac fibrosis A Thiele, N Beyhoff, A Blumrich, D Ritter, J Grune, E Smeir, K Luettges, ... EUROPEAN JOURNAL OF HEART FAILURE 21, 9-9, 2019 | | 2019 |
| Pharmacological Inhibition of Adipose Triglyceride Lipase by Atglistatin Improves Cardiac Function in Isoproterenol-Induced Cardiomyopathy A Thiele, N Beyhoff, A Blumrich, D Ritter, R Klopfleisch, J Grune, E Smeir, ... Circulation 138 (Suppl_1), A15593-A15593, 2018 | | 2018 |
